Relevant studies have shown that VEGF-C and VEGF-D specifically bind to the receptor VEGFR3 in endothelial cells and activate its downstream signaling pathway to induce the formation of many lymphatic vessel buds toward tumor cells, causing lymphatic vessels to expand into tumor tissue. Here, VEGFD is linked to neoplasm.